Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI

Neuroscience Letters

Volumn 352, Issue 2, 2003, Pages 101-104

  Gomes, Andreia C ^a   Morris, Michael ^a,b   Stawiarz, Leszek ^a   Jönsson, Gun ^c   Putheti, Prabhakar ^d   Bronge, Lena ^a   Link, Hans ^d   Hillert, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Caspase 8; CD95; Gadolinium enhancing lesions; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

CASPASE 10; CASPASE 8; CD3 ANTIGEN; CELL PROTEIN; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; GADOLINIUM; INTERLEUKIN 10; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME ECHOGRAPHY;

EID: 0242558804     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.030     Document Type: Article

References (20)

1. Aggarwal S., Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J. Immunol. 160:1998;1627-1637.
2. Calabresi P.A., Fields N.S., Farnon E.C., Frank J.A., Bash C.N., Kawanashi T., Maloni H., Jacobson S., McFarland H.F. ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions. J. Neuroimmunol. 85:1998;212-219.
3. Fainardi E., Granieri E., Tola M.R., Melchiorri L., Vaghi L., Rizzo R., Castellazzi M., Ceruti S., Paolino E., Baricordi O.R. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules. J. Neuroimmunol. 133:2002;151-159.
4. Furlan R., Filippi M., Bergami A., Rocca M.A., Martinelli V., Poliani P.L., Grimaldi L.M., Desina G., Comi G., Martino G. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. J. Neurol. Neurosurg. Psychiatry. 67:1999;785-788.
5. Gomes A.C., Jönsson G., Mjörnheim S., Olsson T., Hillert J., Grandien A. Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 135:2003;126-134.
6. Hartung H.P., Michels M., Reiners K., Seeldrayers P., Archelos J.J., Toyka K.V. Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology. 43:1993;2331-2335.
7. Huang W.X., Huang M.P., Gomes M.A., Hillert J. Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology. 55:2000;928-934.
8. Kermode A.G., Thompson A.J., Tofts P., MacManus D.G., Kendall B.E., Kingsley D.P., Moseley I.F., Rudge P., McDonald W.I. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain. 113:1990;1477-1489.
9. Kischkel F.C., Lawrence D.A., Tinel A., LeBlanc H., Virmani A., Schow P., Gazdar A., Blenis J., Arnott D., Ashkenazi A. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276:2001;46639-46646.
10. Macchi B., Matteucci C., Nocentini U., Caltagirone C., Mastino A. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis. NeuroReport. 10:1999;399-402.
11. Pender M.P. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet. 351:1998;978-981.
12. Poser C.M., Brinar V.V. Diagnostic criteria for multiple sclerosis. Clin. Neurol. Neurosurg. 103:2001;1-11.
13. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
14. Rieckmann P., Altenhofen B., Riegel A., Kallmann B., Felgenhauer K. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Mult. Scler. 4:1998;178-182.
15. Segal B.M., Cross A.H. Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination. Neurology. 55:2000;906-907.
16. Sharief M.K., Noori M.A., Douglas M.R., Semra Y.K. Upregulated surviving expression in activated T lymphocytes correlates with disease activity in multiple sclerosis. Eur. J. Neurol. 9:2002;503-510.
17. Sprick M.R., Rieser E., Stahl H., Grosse-Wilde A., Weigand M.A., Walczak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J. 21:2002;4520-4530.
18. Wang J., Chun H.J., Wong W., Spencer D.M., Lenardo M.J. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA. 98:2001;13884-13888.
19. Wang J., Zheng L., Lobito A., Chan F.K., Dale J., Sneller M., Yao X., Puck J.M., Straus S.E., Lenardo M.J. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 98:1999;47-58.
20. Zang Y.C., Kozovska M.M., Hong J., Li S., Mann S., Killian J.M., Rivera V.M., Zhang J.Z. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur. J. Immunol. 29:1999;1692-1700.